Apply online for RPTUAS subsidy eligibility — India’s leading pharmaceutical subsidy scheme for WHO GMP & Revised Schedule-M compliance upgradation. Trusted by 150+ pharma companies.
Fill the form below and our expert will call you back
By submitting, you agree to our Terms & Privacy Policy
RPTUAS stands for Revamped Pharmaceutical Technology Upgradation Assistance Scheme. It is the flagship pharmaceutical subsidy scheme India designed to help existing drug manufacturing units upgrade their facilities to meet WHO GMP and Revised Schedule-M standards.
The Government made WHO GMP guidelines and Revised Schedule-M compulsory from January 2026. RPTUAS provides financial support covering up to 20% of investment costs so that companies don’t fall behind due to a lack of funds.
Your pharmaceutical subsidy depends on your average turnover in the last 3 years:
*Subject to compliance with Revised Schedule M and WHO GMP certification
The following investment categories are eligible for RPTUAS subsidy claim:
Here’s why the new RPTUAS scheme is significantly better than the old PTUAS:
Fill the form and our expert will call you back